Explore our comprehensive coverage of alzheimer's disease, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The CMS mandate for blood-based p-tau217 biomarker assays is fundamentally shifting Alzheimer's diagnostics from costly neuroimaging to accessible ven...
Read Full Story →
Medical ResearchIn a monumental June 2026 breakthrough, NIH scientists have successfully utilized CRISPR gene-editin...
Medical ResearchThe FDA has approved the first CRISPR gene therapy for Alzheimer's disease, targeting the APOE4 gene...
